ArticleJournal of the American Society of Nephrology : JASN2026
Laboratory Signs of CKD after Preeclampsia.
Article in Journal of the American Society of Nephrology : JASN, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
key pointsWomen with preeclampsia had a higher risk of incident albuminuria >300 mg/g, eGFR <60 ml/min per 1.73 m 2 , or the composite outcome. The higher risk extended across multiple outcomes, including CKD diagnoses and nephrology referrals. Despite these risks, postpartum monitoring of kidney function was infrequent, limiting opportunities for early detection and intervention.
backgroundPreeclampsia, a systemic hypertensive disorder of pregnancy, has been associated with the risk of kidney failure, an outcome that may take decades to develop. However, its association with early kidney disease, which could be targeted for intervention, remains underexplored. Here, we quantified the risk of CKD, defined by laboratory markers of kidney damage, in women who had a pregnancy complicated by preeclampsia versus a pregnancy without preeclampsia.
methodsThis was a population-based cohort study in Stockholm, Sweden, using inverse probability of treatment weights to minimize confounding. All nulliparous women who had at least one pregnancy ending in live or stillbirth between January 1, 2006, and December 31, 2020, were identified, excluding preexisting hypertension, diabetes, or CKD. Primary outcomes were ( 1 ) albuminuria defined by urine albumin-creatinine ratio >300 mg/g, ( 2 ) eGFR <60 ml/min per 1.73 m 2 , and ( 3 ) composite of albuminuria >300 mg/g and/or eGFR <60 ml/min per 1.73 m 2 .
resultsThe study included 171,693 pregnancies (170,192 women: mean [SD] age, 29 [5] years), of whom 10,538 (6%) had at least one pregnancy complicated by preeclampsia. During a median follow-up of 7.0 years (interquartile range, 3.3-10.5), albuminuria >300 mg/g occurred after 775 pregnancies (0.5%), eGFR <60 ml/min per 1.73 m 2 occurred after 248 pregnancies (0.1%), and the composite outcome occurred after 985 pregnancies (0.6%). Incidence rates per 1000 person-years were higher after preeclampsia versus no preeclampsia for albuminuria >300 mg/g (1.53 versus 0.57), eGFR <60 ml/min per 1.73 m 2 (0.52 versus 0.18), and the composite outcome (2.00 versus 0.73). Weighted hazard ratios were 2.53 (95% confidence interval [CI], 2.04 to 3.13) for albuminuria >300 mg/g, 2.18 (95% CI, 1.49 to 3.19) for eGFR <60 ml/min per 1.73 m 2 , and 2.43 (95% CI, 2.01 to 2.95) for the composite outcome. In the first postpartum year, 2080 (20%) and 1043 (10%) of women with preeclampsia had serum creatinine or urine albumin testing, respectively.
conclusionsPreeclampsia was associated with a higher risk of laboratory signs of early kidney damage. There were low rates of postpartum kidney function monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.